Crigler-najjar Syndrome Type 1
Description
Crigler-Najjar syndrome type 1 (CNS1) is the most severe form of CNS (see this term), a hereditary disorder of hepatic bilirubin conjugation, characterized by severe neonatal unconjugated hyperbilirubinemia due to a complete absence of hepatic bilirubin glucuronosyltransferase (BGT).
Clinical Features
Top most frequent phenotypes and symptoms related to Crigler-najjar Syndrome Type 1
- Intellectual disability
- Seizures
- Hearing impairment
- Delayed speech and language development
- Tremor
- Abnormality of the liver
- Memory impairment
- Infantile muscular hypotonia
- Prolonged neonatal jaundice
- Biliary tract abnormality
And another 4 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Crigler-najjar Syndrome Type 1 Is also known as hereditary unconjugated hyperbilirubinemia type 1, bilirubin uridinediphosphate glucuronosyltransferase deficiency type 1, ugt deficiency type 1, bilirubin-ugt deficiency type 1.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Crigler-najjar Syndrome Type 1 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
GeneAware Complete Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
100 % |
GeneAware Complete Panel Version 2 (Male).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...)
View the complete list with 129 more genes
Specificity
1 %
Genes
100 % |
Gilbert syndrome/Irinotecan toxicity.
By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).
UGT1A1
Specificity
100 %
Genes
100 % |
UGT1A1 Irinotecan Toxicity.
By Molecular Diagnostic Laboratory University of Alberta (Canada).
UGT1A1
Specificity
100 %
Genes
100 % |
Liver Diseases Deletion/duplication panel.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
SLC25A13, SLC27A5, SMPD1, HNF1A, HNF1B, TJP2, UGT1A1, ABCG5, ABCG8, NPC2, INVS, CFTR, NPHP4, PEX26, TMEM216, CTRC, TRMU, DGUOK, DHCR7, CC2D2A , (...)
View the complete list with 24 more genes
Specificity
3 %
Genes
100 % |
UGT1A1 Deletion/duplication analysis.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
UGT1A1
Specificity
100 %
Genes
100 % |
UGT1A1 Sequencing.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
UGT1A1
Specificity
100 %
Genes
100 % |
Liver Diseases Panel by next-generation sequencing (NGS).
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
SCP2, SLC10A1, SLC10A2, SLC25A13, SLC27A5, SMPD1, HNF1A, HNF1B, TJP2, UGT1A1, VPS33B, NEUROG3, ABCG5, ABCG8, NPC2, INVS, DCDC2, HSD3B7, CFTR, NPHP4 , (...)
View the complete list with 52 more genes
Specificity
2 %
Genes
100 % |
You can get up to 69 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like CRANIOSYNOSTOSIS 1; CRS1 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3 INSULINOMA IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W 16Q24.3 MICRODELETION SYNDROME TROPICAL CALCIFIC PANCREATITIS